VEGFA and age-related macular degeneration: In AMD treatment, triamcinolone, one of synthetic glucocorticoids, is prescribed for wet-type AMD patients expected anti-inflammatory outcome [16], and a recent study showed that the corticosteroid fluocinolone can inhibit VEGF expression in a GR-dependent way [17].